SANTEN PHARMACEUTICAL CO., LTD. : Intravitreal VEGF Inhibitor "EYLEA ...

News | 27 November 2012

• Print This

Osaka, November 27, 2012 - Bayer Yakuhin, Ltd. (Osaka, hereafter Bayer Yakuhin) and Santen Pharmaceutical Co., Ltd. (Osaka, hereafter Santen) today launched the intravitreal VEGF* inhibitor "EYLEA

Click on the link to read the full article at 4-traders
(This link will open in a new window)